Form 4: PACS Group Director Receives RSU Grant

Director Patrick Hugh Conway was granted 4,660 restricted stock units in PACS Group, Inc. as part of standard equity compensation.

Summary

• Director Patrick Hugh Conway acquired 4,660 restricted stock units (RSUs) of PACS Group, Inc. common stock.
• The transaction occurred on June 10, 2026.
• The RSUs represent a right to receive one share of common stock per unit upon vesting.
• The total beneficial ownership for the director following this transaction is 8,157 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standardized vesting schedule tied to continued service.

Negatives

• None identified; this is a routine equity grant disclosure.

Risks

• Vesting is subject to the director's continued service to the issuer.

Future Outlook

The RSUs are scheduled to vest on June 10, 2027, or the date of the next annual meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-executive directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the healthcare services sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for publicly traded companies in the U.S.
• The vesting period of one year is typical for annual director equity awards.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity incentive grant.

Next Steps

• Vesting of RSUs on June 10, 2027, or the date of the next annual meeting.

Key Dates

Keywords

PACS Group, PACS, Form 4, Insider Trading, Restricted Stock Units, Director Compensation